This is only a test.
Patients with breast cancer whose health insurance plans included prescription drug benefits were 10% more likely to start important hormonal therapy than patients who did not have prescription drug coverage.
Late-onset remission in patients with mucosa-associated lymphoid tissue (MALT) lymphoma treated with thalidomide or lenalidomide.
A recent study examined the impact of early palliative care (EPC) on quality of life for patients with advanced cancer.
Overweight and obesity may be a new challenge in the care of patients with oropharyngeal squamous cell carcinoma (OPSCC).
Men undergoing active surveillance for low-risk prostate cancer may not be receiving proper monitoring.
A novel immunotherapeutic approach improved outcomes for patients with advanced bladder cancer, according to a recent study.
With some training and selective food reinforcement, pigeons performed as well as humans in categorizing digitized slides and mammograms showing benign and malignant human breast tissue.
The impact on PSA screening and prostate cancer incidence before and after the 2012 USPSTF screening recommendations were examined in two recent studies.
Receipt of the 21-gene recurrence score assay (RS) impacts breast cancer treatment and health care costs.
New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good health care structures in place.
International Experts Call for Investigations Into Long-Term Management Options for Select Patients With Advanced Breast Cancer
International experts have called for a clinical trial to investigate the best ways for identifying and treating a small but important group of patients with advanced breast cancer who can survive for long periods without their disease progressing.
Patients With Advanced Breast Cancer Address an International Conference About Misleading Disease-Specific Messages
Patients with advanced breast cancer spoke out about the damaging messages some organizations issue about advanced breast cancer. They need to be identified and educated to change the way they talk about the disease.
The more children a woman has or whether she has undergone tubal ligation lowers her risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 NCRI Cancer Conference.
A widely available, inexpensive blood test can predict outcomes and guide treatment in pancreatic cancer; however, only 1 in 5 US patients with the disease have the blood test.
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- New Blood Test Improves Screening for Prostate Cancer
- Blood Sample Offers a New Way of Detecting Cancer
- Nanoliposomal Irinotecan Extends Survival in Metastatic Pancreatic Cancer
- Timing Matters for Pegfilgrastim Administration
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- ASH 2015 Placeholder
- Prescription Coverage Impacts Treatment Adherence in Breast Cancer, Even for Low-cost Drugs
- Late-onset Remission Seen in Patients With Lymphoma Treated with Immunomodulatory Drugs
- Impact of Early Palliative Care Varies Depending on Patient Age, Gender
- Weight Gain May Follow Head and Neck Cancer Operations
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|